Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase NA 7Phase 1 5Phase 4 4Phase 3 4Phase EARLY_PHASE1 3Phase 2/3 3Phase 1/2 2

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1

Conditions

Ulcer 1Recurrent respiratory papillomatosis 1Papilloma 1Melanoma 1Hemangioma, Capillary 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Propranolol × Clear all
NCT06798363 2026-03-16

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

West China Hospital

Phase 2/3 Recruiting
40 enrolled

Ulcer, Hemangioma, Capillary

NCT02962947 2016-11-15

MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients

Azienda Sanitaria di Firenze

Phase 2/3 Unknown
546 enrolled
Dermatologic

Melanoma

NCT01058317 2013-11-21

Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis

Massachusetts Eye and Ear Infirmary

Phase 2/3 Withdrawn

Recurrent respiratory papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡